PrecisCa

PrecisCa supports patients, their caregivers, and health care providers at every step of their cancer journeys from diagnosis to remission, with up-to-date education on the latest advancements in cancer care and access to leading specialists to analyze patient scenarios

https://precisca.com/

 

PrecisCa
R

Treatment of Oligometastatic Disease in Breast Cancer

By PrecisCa FEATURING Reshma L. Mahtani
By PrecisCa FEATURING Reshma L. Mahtani
0 views
June 17, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy
Breast
27:54
PrecisCa

Expert Panel Case Discussion: 59 y/o Woman With Stage IV ER/PR+ HER2…

Feat. L. Wu, N. Dempsey, J. O'Shaughnessy, R. L. Mahtani, A. O'Dea, H. Rugo, M. Pegram, L. Carcas, C. Shah, F. Vicini, T. Buchholz
11:33
PrecisCa

Meta-Analysis of 16,500 Women With Early Stage BC in 13 Randomized T…

Feat. M. Pegram
07:34
PrecisCa

Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Anal…

Feat. M. Pegram
04:04
PrecisCa

What Is Trastuzumab-Deruxtecan and What Should I Know When I'm …

Feat. L. Littlejohn
03:45
PrecisCa

Different Types of Molecular Testing and Why Are They Done

Feat. L. Littlejohn
08:40
PrecisCa

Managing Common Toxicities From CDK4/6i

Feat. E. Shonkwiler
14:40
PrecisCa

Expert Panel Case Discussion: 59 y/o With Stage 4 TNBC

Feat. R. L. Mahtani, W. Gradishar, J. O'Shaughnessy
18:52
PrecisCa

Expert Case Discussion: 68 y/o With HR+/HER2- mBC With Progression t…

Feat. R. L. Mahtani, W. Gradishar, J. O'Shaughnessy
03:38
PrecisCa

Omitting Radiotherapy Following Breast Conserving Surgery in Low Ris…

Feat. R. L. Mahtani
03:00
PrecisCa

Treatment of Oligometastatic Disease in Breast Cancer

Feat. R. L. Mahtani
03:14
PrecisCa

Advanced Breast Cancer Updates: Continuation of Ribociclib After Pro…

Feat. R. L. Mahtani
02:32
PrecisCa

Overall Survival Data for Palbociclib in the PALOMA-2 Trial for HR+/…

Feat. R. L. Mahtani
03:09
PrecisCa

Use of Capivasertib in Relapsed/Refractory HR+ Breast Cancer

Feat. R. L. Mahtani
09:47
PrecisCa

Breast Tumor Board Case Discussion of a 50 y/o Female With Recurrent…

Feat. A. O'Dea, T. King, C. Shah, M. Pegram, M. Jochelson
06:35
PrecisCa

How to Optimally Utilize Trastuzumab Deruxtecan for HER2+ mBC

Feat. J. O'Shaughnessy
04:08
PrecisCa

Current Approach to mTNBC Treatment

Feat. S. Hurvitz
03:44
PrecisCa

Treatment of Metastatic HER2+ BC With Organ Dysfunction Through Vari…

Feat. S. Hurvitz
04:51
PrecisCa

Omitting Radiation Therapy After Lumpectomy for Patients With EBC: F…

Feat. T. Buchholz
21:26
PrecisCa

Breast Tumor Board Case Discussion: 27 y/o Female With Stage IV pT3N…

Feat. W. Gradishar, S. Hurvitz, N. Wolmark, R. Butler, T. Buchholz
12:18
PrecisCa

Breast Tumor Board Case Discussion: 59 y/o Female With Stage IV IDC …

Feat. A. O'Dea, N. Wolmark, T. Buchholz, S. Hurvitz, M. Jochelson